Sort   by:  
 Page size 
UnknownEvaluation of 6 MALDI-Matrices for 10 μm Lipid Imaging and On-Tissue MSn with AP-MALDI-Orbitrap.
Not available
S-EPMC9074099 | biostudies-literature
UnknownLow-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes.
Not available
S-EPMC6105329 | biostudies-literature
UnknownFrom science to policy: How European HBM indicators help to answer policy questions related to phthalates and DINCH exposure.
Not available
S-EPMC9758616 | biostudies-literature
UnknownMultiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.
Not available
S-EPMC7615263 | biostudies-literature
UnknownTowards defining the surgical workforce for children: a geospatial analysis in Brazil.
Not available
S-EPMC7202732 | biostudies-literature
UnknownSubcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
Not available
S-EPMC8362593 | biostudies-literature
UnknownClinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study.
Not available
S-EPMC9034855 | biostudies-literature
UnknownEffect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
Not available
S-EPMC8808333 | biostudies-literature
UnknownResidual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.
Not available
S-EPMC12860639 | biostudies-literature
UnknownPrevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study.
Not available
S-EPMC10005893 | biostudies-literature
Sort   by:  
 Page size